Rethinking Sources Of Innovation In Asia As The “Pendulum Swings Back” To Japan – BIO Asia
This article was originally published in PharmAsia News
Executive Summary
Companies like Merck Serono, AstraZeneca and Eisai are reshuffling R&D operations in Asia to capitalize on new hubs of innovation.